Skip to main content

Vulnerable Pakistanis to get priority for Chinese COVID-19 vaccine


By Masood Sattar Khan
(Pakistan News & Features Services)

China will provide a coronavirus vaccine candidate developed by Sinopharm, a unit of the China National Pharmaceutical Group, to Pakistan as part of a trial agreement.

The University of Karachi and Sinopharm are set to collaborate on vaccine trials and Pakistan will get vaccine doses sufficient to vaccinate one-fifth of its population. 

According to reports, the initial doses will be used to vaccinate the most vulnerable among the Pakistani population including the elderly, healthcare workers and people with medical conditions associated with serious cases of COVID-19.

Earlier in April, Sinopharm had invited the National Institute of Health (NIH), Islamabad, to collaborate in conducting clinical trials of its inactivated vaccine for COVID-19 in Pakistan. 

In a letter sent to NIH Executive Director Maj Gen Dr Aamer Ikram, the general manager of China Sinopharm International Corp, Li Can, had expressed the hope that a successful clinical trial in Pakistan will make it one of the first few countries for the launch of a Covid-19 vaccine. 

The NIH official was then reported to have stated that although clearances were needed for the purpose, the collaboration could be a great thing for Pakistan. Meanwhile, researchers have said that Sinopharm’s coronavirus vaccine candidate appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials. 

The candidate has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval. 

Sinopharm is testing the potential vaccine in the United Arab Emirates (UAE) in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site. 

The shot did not cause any serious side effects, according to a paper published in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes. The results were based on data from 320 healthy adults in Phase 1 and 2 trials. 

Sinopharm’s chairman told state media last month that a potential vaccine could be ready by the end of this year with Phase 3 testing expected to be completed in about three months. 

The novel coronavirus, which has killed more than 750,000 people globally, has prompted a race to develop a vaccine. More than 150 candidate vaccines are being developed and tested around the world. China is leading the development of at least eight vaccine candidates in different stages of clinical trials.
Labels:

Comments

Post a Comment

Popular posts from this blog

Dr. Zeelaf Munir Calls for Supply Chain Reforms to Strengthen Pakistan’s Food Security at Breathe Pakistan 2026

  Karachi: At the recently held Breathe Pakistan 2026 conference, where EBM participated as the principal partner, the company’s Managing Director and CEO Dr. Zeelaf Munir emphasized the urgent need to rebuild Pakistan’s agricultural supply chain to ensure long-term food security and sustainable development. Addressing participants at the event, Dr. Zeelaf Munir stated that while initiatives such as improved seeds, affordable credit facilities, and crop insurance are important, they alone cannot transform the lives of smallholder farmers unless the supply chain that follows agricultural production is fundamentally restructured. She highlighted that Pakistan’s food security is being “made or lost” within the post-farm supply chain, stressing that inefficiencies in storage, transportation, distribution, and market access continue to limit the benefits reaching farmers and consumers alike. Dr. Munir further noted that the transformation required in Pakistan’s agri-food sector must ...
Post a Comment
Read more

Constitution, Justice and Public Trust Essential for National Unity: Speakers

Bazm-e-Mukalma Pakistan organized the 39th Professor Karrar Hussain Memorial Lecture with a question-and-answer session at Rabat Hall, Bahadurabad, on “Lack of National Unity: Causes and Remedies.” Speakers and senior analysts Syed Muzafar Ejaz and Mazhar Abbas said national unity could not be achieved through slogans alone, but required justice, equality, constitutional supremacy, democratic continuity and public trust. They highlighted religious, linguistic, provincial and class-based divisions as major challenges to national cohesion. Mazhar Abbas stressed the importance of institutions working within their constitutional limits, freedom of the press and respect for the people’s right to choose their representatives. The session concluded with an interactive question-and-answer session on national identity, constitutional supremacy, the political system, provincial grievances and the role of state institutions.
Post a Comment
Read more

KDSP: Empowering Individuals with Down Syndrome in Karachi

The Karachi Down Syndrome Program (KDSP), a beacon of hope and support, is making significant strides in empowering individuals with Down syndrome in the city. Founded in March 2014 by a group of passionate parents and individuals, KDSP addresses the critical need for comprehensive resources and platforms for those with Down syndrome in Karachi. Bridging the Gap: A Mission of Advocacy and Inclusion KDSP operates as a non-profit organization with a clear mission: to advocate for the value, acceptance, and inclusion of individuals with Down syndrome. Recognizing the limited support and resources available locally, KDSP was established to provide a nurturing environment where individuals with Down syndrome can lead independent and fulfilling lives. A Lifelong Journey of Support Understanding the unique needs of individuals with Down syndrome and their families, KDSP offers unwavering support from the moment a family receives a diagnosis.  They embark on a journey with each family, pro...
Post a Comment
Read more